Skip to main content
. 2021 Nov 23;8:782231. doi: 10.3389/fmed.2021.782231

Figure 2.

Figure 2

A 58-year-old man was diagnosed with peritoneal metastasis due to post-operative re-examination of pancreatic cancer. After receiving Carrelizumab immunosuppressive therapy, 68Ga-FAPI PET/CT was performed [(A): after 1 cycle; (B): after 4 cycles]. After the first cycle, the thyroid showed diffuse increased FAPI uptake with SUVmax of 6.1, and TBR 7.46; blood analysis showed FT3 2.86, FT4 1.18, TSH 13.193, TgAb 12.06, and TPOAb <0.05; after the fourth cycle, the thyroid also showed diffuse increased FAPI uptake with SUVmax of 3.9, and TBR 6.26; blood analysis showed FT3 2.49, FT4 1.02, TSH 7.096, TgAb <0.12, and TPOAb <0.05; Finally, a diagnosis of immune-related thyroiditis was made.